Mendez-Sanchez N - Search Results

1

New Aspects of Lipotoxicity in Nonalcoholic Steatohepatitis.

Mendez-Sanchez N, Cruz-Ramon VC, Ramirez-Perez OL, Hwang JP, Barranco-Fragoso B, Cordova-Gallardo J. Mendez-Sanchez N, et al. Int J Mol Sci. 2018 Jul 13;19(7):2034. doi: 10.3390/ijms19072034. Int J Mol Sci. 2018. PMID: 30011790 Free PMC article. Review.

2

Current concepts in the pathogenesis of nonalcoholic fatty liver disease.

Méndez-Sánchez N, Arrese M, Zamora-Valdés D, Uribe M. Méndez-Sánchez N, et al. Liver Int. 2007 May;27(4):423-33. doi: 10.1111/j.1478-3231.2007.01483.x. Liver Int. 2007. PMID: 17403181 Review.

3

Treating nonalcoholic fatty liver disease.

Méndez-Sánchez N, Arrese M, Zamora-Valdés D, Uribe M. Méndez-Sánchez N, et al. Liver Int. 2007 Nov;27(9):1157-65. doi: 10.1111/j.1478-3231.2007.01567.x. Liver Int. 2007. PMID: 17919226 Review.

4

Prevalence of type 2 diabetes mellitus and chronic liver disease: a retrospective study of the association of two increasingly common diseases in Mexico.

Kobashi-Margáin RA, Gutiérrez-Grobe Y, Ponciano-Rodríguez G, Uribe M, Méndez-Sánchez N. Kobashi-Margáin RA, et al. Ann Hepatol. 2010 Jul-Sep;9(3):282-8. Ann Hepatol. 2010. PMID: 20720269 Free article.

5

High coffee intake is associated with lower grade nonalcoholic fatty liver disease: the role of peripheral antioxidant activity.

Gutiérrez-Grobe Y, Chávez-Tapia N, Sánchez-Valle V, Gavilanes-Espinar JG, Ponciano-Rodríguez G, Uribe M, Méndez-Sánchez N. Gutiérrez-Grobe Y, et al. Ann Hepatol. 2012 May-Jun;11(3):350-5. Ann Hepatol. 2012. PMID: 22481454 Free article.

6

Validation study of systems for noninvasive diagnosis of fibrosis in nonalcoholic fatty liver disease in Latin population.

Pérez-Gutiérrez OZ, Hernández-Rocha C, Candia-Balboa RA, Arrese MA, Benítez C, Brizuela-Alcántara DC, Méndez-Sánchez N, Uribe M, Chávez-Tapia NC. Pérez-Gutiérrez OZ, et al. Ann Hepatol. 2013 May-Jun;12(3):416-24. Ann Hepatol. 2013. PMID: 23619258 Free article.

7

Metabolic syndrome and nonalcoholic fatty liver disease. The role of endothelial progenitor cells.

Gutiérrez-Grobe Y, Gavilanes-Espinar JG, Masso-Rojas FA, Sánchez-Valle V, Páez-Arenas A, Ponciano-Rodríguez G, Chávez-Tapia NC, Uribe M, Méndez-Sánchez N. Gutiérrez-Grobe Y, et al. Ann Hepatol. 2013 Nov-Dec;12(6):908-14. Ann Hepatol. 2013. PMID: 24114821 Free article.

8

The prevalence of nonalcoholic fatty liver disease in the Americas.

López-Velázquez JA, Silva-Vidal KV, Ponciano-Rodríguez G, Chávez-Tapia NC, Arrese M, Uribe M, Méndez-Sánchez N. López-Velázquez JA, et al. Ann Hepatol. 2014 Mar-Apr;13(2):166-78. Ann Hepatol. 2014. PMID: 24552858 Free article. Review.

9

Common features of the metabolic syndrome and nonalcoholic fatty liver disease.

Almeda-Valdes P, Aguilar-Olivos N, Uribe M, Méndez-Sánchez N. Almeda-Valdes P, et al. Rev Recent Clin Trials. 2014;9(3):148-58. doi: 10.2174/1574887109666141216103908. Rev Recent Clin Trials. 2014. PMID: 25514910 Review.

10

Portal vein thrombosis: what is new?

Manzano-Robleda Mdel C, Barranco-Fragoso B, Uribe M, Méndez-Sánchez N. Manzano-Robleda Mdel C, et al. Ann Hepatol. 2015 Jan-Feb;14(1):20-7. Ann Hepatol. 2015. PMID: 25536638 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

377 results

Search Page